You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Celgene

Showing 26 - 50 of 1,034
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia(CLL), Small Lymphocytic Lymphoma Trial in Hackensack (Revlimid, Azacitidine)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia(CLL)
  • Small Lymphocytic Lymphoma
  • Hackensack, New Jersey
    Hackensack University Medical Center
Jun 24, 2022

Melanoma Trial in Houston (ABI-007, Ipilimumab, Phone Call)

Completed
Has Results
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 12, 2022

Apremilast in Psoriatic Arthritis in Real-life Clinical Practice

Active, not recruiting
  • Psoriatic Arthritis
    • Thessaloníki, Greece
      Euromedica Private Clinic
    Dec 20, 2021

    Colorectal Cancer Trial in Baltimore (Oral CC-486, Romidepsin, MK-3475)

    Completed
    • Colorectal Cancer
    • Oral CC-486
    • +2 more
    • Baltimore, Maryland
      Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Mar 21, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Sacramento (Lenalidomide)

    Completed
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • Sacramento, California
      University of California Davis
    Mar 8, 2022

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in Friedrichshafen (OFF, FOLFIRI Protocol)

    Terminated
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • OFF
    • FOLFIRI Protocol
    • Friedrichshafen, Germany
      Praxis für Innere Medizin
    Dec 21, 2021

    Ductal Adenocarcinoma of the Pancreas Trial in Würzburg (Gem/nab-Pac, FOLFIFINOX)

    Completed
    • Ductal Adenocarcinoma of the Pancreas
    • Würzburg, Bayern, Germany
      Universitätsklinikum Würzburg/Comprehensive Cancer Center Mainfr
    Dec 14, 2021

    Leukemia, Leukemia, Myeloid, Monocytic Leukemia Trial in Palo Alto (Enasidenib mesylat dose escalation)

    Recruiting
    • Leukemia
    • +2 more
    • Enasidenib mesylat dose escalation
    • Palo Alto, California
      Stanford Cancer Institute
    May 12, 2022

    Multiple Myeloma Trial in Worldwide (Iberdomide)

    Recruiting
    • Multiple Myeloma
    • Nantes, France
    • +3 more
    Aug 16, 2022

    Mantle Cell Lymphoma Trial in United States (lenalidomide, rituximab)

    Active, not recruiting
    Has Results
    • Mantle Cell Lymphoma
    • Tampa, Florida
    • +3 more
    Mar 26, 2022

    MDS Trial in United States (Lenalidomide, Luspatercept)

    Recruiting
    • Myelodysplastic Syndromes
    • Miami, Florida
    • +5 more
    Sep 28, 2022

    Acne Conglobata Trial in Frankfurt (Apremilast)

    Completed
    • Acne Conglobata
    • Frankfurt, Hessia, Germany
      University Hospital Frankfurt
    Mar 1, 2022

    Multiple Myeloma Trial in Aurora, New York (Clarithromycin, Lenalidomide, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Aurora, Colorado
    • +1 more
    Feb 1, 2022

    Early Palliative Care on Quality of Life of Advanced Pancreas

    Completed
    • Advanced Cancer
    • Palliative care assessment
    • Winnipeg, Manitoba, Canada
      Victoria General Hospital Buhler Cancer Centre
    Feb 1, 2022

    Plasmacytoma Trial in United Kingdom (Lenalidomide, Dexamethasone, No further treatment)

    Active, not recruiting
    • Plasmacytoma
    • Bath, United Kingdom
    • +12 more
    Dec 22, 2022

    Diffuse Intrinsic Pontine Glioma, Pediatric Brainstem Glioma, Pediatric Brainstem Gliosarcoma, Recurrent Trial in Boston

    Active, not recruiting
    • Diffuse Intrinsic Pontine Glioma
    • +5 more
    • Boston, Massachusetts
    • +1 more
    May 3, 2022

    Chronic Lymphocytic Leukemia Trial in New York (thalidomide, lenalidomide, rituximab)

    Completed
    Has Results
    • Chronic Lymphocytic Leukemia
    • New York, New York
      Weill Cornell Medical College
    Dec 23, 2021

    Unresectable Pancreatic Carcinoma Trial in Herlev, Oslo (Tocilizumab, Gemcitabine, nab-Paclitaxel)

    Active, not recruiting
    • Unresectable Pancreatic Carcinoma
    • Herlev, Denmark
    • +1 more
    Mar 15, 2022

    Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Baltimore, Boston, Columbus (Enasidenib)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Chronic Myelomonocytic Leukemia
    • Baltimore, Maryland
    • +3 more
    Aug 8, 2022

    Multiple Myeloma Trial (Daratumumab, Cyclophosphamide, Pomalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Oct 8, 2021

    Multiple Sclerosis Trial in France (Clinical assessment, Classical cognitive evaluation of several domains:, Ecological

    Not yet recruiting
    • Multiple Sclerosis
    • Clinical assessment
    • +5 more
    • Bordeaux, France
    • +6 more
    Nov 3, 2022

    Lymphoma, Large B-Cell, Diffuse Trial in Saint Louis, Columbus (Brentuximab vedotin, Lenalidomide)

    Completed
    • Lymphoma, Large B-Cell, Diffuse
    • Saint Louis, Missouri
    • +1 more
    Feb 16, 2022

    Solid Organ Malignancies, Adenoidcystic Carcinoma, Neuroendocrine Tumors Trial in Atlanta (Lenalidomide, Everolimus)

    Completed
    Has Results
    • Solid Organ Malignancies
    • +2 more
    • Atlanta, Georgia
    • +1 more
    Nov 19, 2021

    Myelofibrosis Trial in United States (Ruxolitinib, Thalidomide)

    Active, not recruiting
    • Myelofibrosis
    • Middletown, New Jersey
    • +6 more
    Aug 23, 2022

    PTCL Trial in Long Beach, New Haven, Charlottesville (Azacytidine, Romidepsin, Belinostat)

    Recruiting
    • PTCL
    • Long Beach, California
    • +2 more
    Mar 1, 2022